Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma
NCT ID: NCT00980707
Last Updated: 2012-01-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
10 participants
INTERVENTIONAL
2009-08-31
2010-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Induced Sputum Study (0000-065)
NCT00623714
Measurements of Inflammation Induced by Allergen Inhalation Challenge in Mild Allergic Asthma
NCT06411886
Biomarkers in Exhaled Breath From Asthmatic Patients
NCT00635271
Study of the Inflammation and Airway Changes That Occur After Exposure to Allergen in Asthmatics
NCT02230189
Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity
NCT00217854
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
inhaled corticosteroid
All asthmatics will start inhaled corticosteroids.
Inhaled corticosteroid (fluticasone)
inhaled fluticasone 220 ug/bid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inhaled corticosteroid (fluticasone)
inhaled fluticasone 220 ug/bid
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Benaroya Research Institute
OTHER
GlaxoSmithKline
INDUSTRY
Associated Scientists to Help Minimize Allergies
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leonard C Altman, MD
Role: PRINCIPAL_INVESTIGATOR
Associated Scientists to Help Minimize Allergies
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Associated Scientists to Help Minimize Allergies
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AI-005 versican
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.